Filizoglu, N. Et Al. 2024. Value of 68Ga-DOTATATE PET/CT in Follow-up of Renal Cell Carcinoma with Multiple Atypical Metastatic Sites. Clinical Nuclear Medicine , vol.49, no.12 .

Filizoglu, N., ÖZGÜVEN, S., ÖNEŞ, T., TUROĞLU, H. T., & ERDİL, T. Y., (2024). Value of 68Ga-DOTATATE PET/CT in Follow-up of Renal Cell Carcinoma with Multiple Atypical Metastatic Sites. Clinical Nuclear Medicine , vol.49, no.12.

Filizoglu, Nuh Et Al. "Value of 68Ga-DOTATATE PET/CT in Follow-up of Renal Cell Carcinoma with Multiple Atypical Metastatic Sites," Clinical Nuclear Medicine , vol.49, no.12, 2024

Filizoglu, Nuh Et Al. "Value of 68Ga-DOTATATE PET/CT in Follow-up of Renal Cell Carcinoma with Multiple Atypical Metastatic Sites." Clinical Nuclear Medicine , vol.49, no.12, 2024

Filizoglu, N. Et Al. (2024) . "Value of 68Ga-DOTATATE PET/CT in Follow-up of Renal Cell Carcinoma with Multiple Atypical Metastatic Sites." Clinical Nuclear Medicine , vol.49, no.12.

@article{article, author={Nuh Filizoglu Et Al. }, title={Value of 68Ga-DOTATATE PET/CT in Follow-up of Renal Cell Carcinoma with Multiple Atypical Metastatic Sites}, journal={Clinical Nuclear Medicine}, year=2024}